4//SEC Filing
Nolan Sean P. 4
Accession 0001209191-21-042107
CIK 0001806310other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:02 PM ET
Size
5.4 KB
Accession
0001209191-21-042107
Insider Transaction Report
Form 4
Nolan Sean P.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-17+15,500→ 15,500 totalExercise: $25.04Exp: 2031-06-17→ Common Stock (15,500 underlying)
Footnotes (1)
- [F1]The shares vest on the earlier of June 17, 2022 or the next annual stockholders meeting, subject to continued service as a director though the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001569926
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:02 PM ET
- Size
- 5.4 KB